Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has results × Hospice × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 1613 Neoplasms 1170 Carcinoma, Non-Small-Cell Lung 1084 Prostatic Neoplasms 890 Multiple Myeloma 699 Leukemia, Myeloid, Acute 633 Neoplasm Metastasis 593 Colorectal Neoplasms 565 Lung Neoplasms 562 Melanoma 551 Lymphoma 536 Leukemia 494 Lymphoma, Non-Hodgkin 475 Ovarian Neoplasms 440 Leukemia, Lymphocytic, Chronic, B-Cell 440 Pancreatic Neoplasms 419 Precursor Cell Lymphoblastic Leukemia-Lymphoma 394 Recurrence 383 Myelodysplastic Syndromes 350 Lymphoma, Follicular 335 Head and Neck Neoplasms 323 Glioblastoma 319 Carcinoma, Renal Cell 316 Brain Neoplasms 316 Lymphoma, Large B-Cell, Diffuse 305 Hodgkin Disease 280 Carcinoma, Hepatocellular 278 Squamous Cell Carcinoma of Head and Neck 259 Lymphoma, Mantle-Cell 252 Sarcoma 230

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡